Stock Track | Baxter Soars 10.21% in Pre-Market on Strong Q2 Earnings Beat and Upgraded Full-Year Guidance

Stock Track

Jul 30

Baxter International Inc. (NYSE: BAX) surged 10.21% in pre-market trading on Thursday, as investors reacted to a stellar second-quarter earnings report that significantly exceeded analyst expectations.

The healthcare company reported adjusted earnings per share of $0.54, crushing the consensus estimate of $0.37 by 45.95%. Quarterly revenue came in at $2.96 billion, also well above the $2.795 billion Wall Street forecast. The strong performance marks a sharp turnaround from a disappointing fourth-quarter report earlier this year.

Adding to the positive momentum, Baxter raised its full-year outlook for both sales and earnings. The company now expects adjusted EPS from continuing operations in the range of $1.95 to $2.15, compared to the analyst consensus of $1.91, and reported sales growth of 3% to 4% for the full year. Several investment banks had already raised their price targets ahead of the release, signaling growing confidence in the company's strategic initiatives.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1187810692"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187810692\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187810692?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 19:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187810692","market":"hk","top_or_hot":-1,"title":"Stock Track | Baxter Soars 10.21% in Pre-Market on Strong Q2 Earnings Beat and Upgraded Full-Year Guidance","media":"Stock Track","content":"<p>Baxter International Inc. (NYSE: BAX) surged 10.21% in pre-market trading on Thursday, as investors reacted to a stellar second-quarter earnings report that significantly exceeded analyst expectations.</p><p>The healthcare company reported adjusted earnings per share of $0.54, crushing the consensus estimate of $0.37 by 45.95%. Quarterly revenue came in at $2.96 billion, also well above the $2.795 billion Wall Street forecast. The strong performance marks a sharp turnaround from a disappointing fourth-quarter report earlier this year.</p><p>Adding to the positive momentum, Baxter raised its full-year outlook for both sales and earnings. The company now expects adjusted EPS from continuing operations in the range of $1.95 to $2.15, compared to the analyst consensus of $1.91, and reported sales growth of 3% to 4% for the full year. Several investment banks had already raised their price targets ahead of the release, signaling growing confidence in the company's strategic initiatives.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Baxter Soars 10.21% in Pre-Market on Strong Q2 Earnings Beat and Upgraded Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Baxter Soars 10.21% in Pre-Market on Strong Q2 Earnings Beat and Upgraded Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-30 19:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Baxter International Inc. (NYSE: BAX) surged 10.21% in pre-market trading on Thursday, as investors reacted to a stellar second-quarter earnings report that significantly exceeded analyst expectations.</p><p>The healthcare company reported adjusted earnings per share of $0.54, crushing the consensus estimate of $0.37 by 45.95%. Quarterly revenue came in at $2.96 billion, also well above the $2.795 billion Wall Street forecast. The strong performance marks a sharp turnaround from a disappointing fourth-quarter report earlier this year.</p><p>Adding to the positive momentum, Baxter raised its full-year outlook for both sales and earnings. The company now expects adjusted EPS from continuing operations in the range of $1.95 to $2.15, compared to the analyst consensus of $1.91, and reported sales growth of 3% to 4% for the full year. Several investment banks had already raised their price targets ahead of the release, signaling growing confidence in the company's strategic initiatives.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAX","symbol_name":"百特国际","start_time":0,"source_url":"","article_id":"1187810692","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187810692","pubTimestamp":1785410322,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Baxter International Inc. (NYSE: BAX) surged 10.21% in pre-market trading on Thursday, as investors reacted to a stellar second-quarter earnings report that significantly exceeded analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BAX":"百特国际"},"translate_title":"股票跟踪 | 由于第二季度盈利强劲并上调全年指引，百特盘前股价飙升 10.21%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAX":1},"content_text":"Baxter International Inc. (NYSE: BAX) surged 10.21% in pre-market trading on Thursday, as investors reacted to a stellar second-quarter earnings report that significantly exceeded analyst expectations.The healthcare company reported adjusted earnings per share of $0.54, crushing the consensus estimate of $0.37 by 45.95%. Quarterly revenue came in at $2.96 billion, also well above the $2.795 billion Wall Street forecast. The strong performance marks a sharp turnaround from a disappointing fourth-quarter report earlier this year.Adding to the positive momentum, Baxter raised its full-year outlook for both sales and earnings. The company now expects adjusted EPS from continuing operations in the range of $1.95 to $2.15, compared to the analyst consensus of $1.91, and reported sales growth of 3% to 4% for the full year. Several investment banks had already raised their price targets ahead of the release, signaling growing confidence in the company's strategic initiatives.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}